Why demand is rising for secure and climate-controlled gene therapy services
Pharmaceutical Technology
JUNE 19, 2023
“Cell and gene therapies are not your typical clinical supply chain. It’s much more complex and it has to be 100% correct, or else patients are really at risk,” explains Michael MacNeir, vice president of Business Development, Sharp Clinical. The requirements When handling personalised medicines, time is of the essence.
130 
Let's personalize your content